Weekly Variation in Naloxone Possession and Carriage Among People Who Use Opioids in New York City Before and During the COVID-19 Pandemic: A Pre-Post Comparison, 2019-2022 (ICPSR 39341)
Version Date: Aug 14, 2025 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Alex S. Bennett, New York University;
Luther C. Elliott, New York University
https://doi.org/10.3886/ICPSR39341.v1
Version V1
Summary View help for Summary
There is a dearth of research examining how naloxone possession and carriage are impacted by time-varying individual and social determinants, including during the COVID-19 pandemic. This study focuses on 40 people from New York City that use illicit opiods and their Naloxone possession and carriage habits during the COVID-19 pandemic.
Citation View help for Citation
Export Citation:
Funding View help for Funding
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Smallest Geographic Unit View help for Smallest Geographic Unit
City
Restrictions View help for Restrictions
These data may not be used for any purpose other than statistical reporting and analysis. Use of these data to learn the identity of any person or establishment is strictly prohibited. To protect respondent privacy, certain files within this data collection are restricted from general dissemination. To obtain these files, researchers must agree to the terms and conditions of a Restricted Data Use Agreement in accordance with existing ICPSR servicing policies.
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Study Purpose View help for Study Purpose
The purpose of this study is to compare Naloxone possession and use before, during, and after COVID-19.
Study Design View help for Study Design
Weekly ecological momentary assessments (EMA) were used to measure factors associated with naloxone possession and carriage among 40 people who use illicit opioids in New York City for 24 months.
Time Method View help for Time Method
Universe View help for Universe
Adults 18 years of age and older
Unit(s) of Observation View help for Unit(s) of Observation
Data Type(s) View help for Data Type(s)
Mode of Data Collection View help for Mode of Data Collection
Description of Variables View help for Description of Variables
There are quantitative and qualitative variables about drug use, drug cravings, respondent's social life, and information about drug overdose. Respondents were also asked about their observations on drug prevention or drug recovery found in media or their environments.
HideOriginal Release Date View help for Original Release Date
2025-08-14
Version History View help for Version History
2025-08-14 ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:
- Created variable labels and/or value labels.
- Performed recodes and/or calculated derived variables.
Notes
The public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.
ICPSR usually offers files in multiple formats for researchers to be able to access data and documentation in formats that work well within their needs. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR’s Accessibility Center.
One or more files in this data collection have special restrictions. Restricted data files are not available for direct download from the website; click on the Restricted Data button to learn more.
This study is maintained and distributed by the National Addiction and Health Data Archive Program (NAHDAP). NAHDAP is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).